申请人:——
公开号:US20030207879A1
公开(公告)日:2003-11-06
The present invention relates generally to compounds of formula (IA): (IA)
1
the preparation thereof, pharmaceutical formulations thereof, and their use in medicine as potent or selective A
2B
adenosine receptor antagonists and their uses for treating asthma, autoimmune diseases and retinal vascular diseases.
本发明总体上涉及公式(IA)的化合物:(IA)1,其制备方法、药物制剂及其在医学中的应用,作为强效或选择性的A2B腺苷受体拮抗剂,以及用于治疗哮喘、自身免疫疾病和视网膜血管疾病的用途。